Viewing Study NCT00732056


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-31 @ 8:14 PM
Study NCT ID: NCT00732056
Status: COMPLETED
Last Update Posted: 2015-12-24
First Post: 2008-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer
Sponsor: Geron Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Breast Cancer View
None Recurrent Breast Cancer View